City Drug House Exporters | Hepatitis Medicines Supplier to Washington, USA
City Drug House Exporters supplies and exports high-quality hepatitis medicines from India to Washington, USA with trusted pharma solutions and timely global delivery.
Hepcvir L is a prescription antiviral medication manufactured by Cipla, containing a fixed-dose combination of Ledipasvir 90 mg and Sofosbuvir 400 mg. It is primarily used to treat chronic Hepatitis C virus (HCV) infections.
Drug Class & Mechanism of Action
Ledipasvir: An HCV NS5A inhibitor. It interferes with the NS5A protein, which is essential for viral replication and assembly.
Sofosbuvir: A direct-acting NS5B nucleotide polymerase inhibitor. It acts as a prodrug that is converted into its active metabolite to inhibit viral RNA synthesis.
Synergy: Together, the combination prevents the Hepatitis C virus from multiplying and spreading, allowing the virus to be eliminated from the body.
Indications & Usage :
Used to treat chronic HCV infection in adults and children.
It can cure more than 95 %of Hepatitis C cases when taken for a standard duration of 8 to 24 weeks, depending on the viral genotype.
It is a prescription-only drug.
Pharmacokinetics :
Administration: Taken orally once daily, with or without food.
Metabolism: Sofosbuvir is extensively metabolized in the liver to form the active pharmacologic metabolite. Ledipasvir undergoes minor oxidative metabolism.
Excretion: Both components are primarily excreted via the feces (as unchanged drug) and urine.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
City Drug House Exporters supplies and exports high-quality hepatitis medicines from India to Washington, USA with trusted pharma solutions and timely global delivery.
Hepcvir L is a prescription antiviral medication manufactured by Cipla, containing a fixed-dose combination of Ledipasvir 90 mg and Sofosbuvir 400 mg. It is primarily used to treat chronic Hepatitis C virus (HCV) infections.
Drug Class & Mechanism of Action
Ledipasvir: An HCV NS5A inhibitor. It interferes with the NS5A protein, which is essential for viral replication and assembly.
Sofosbuvir: A direct-acting NS5B nucleotide polymerase inhibitor. It acts as a prodrug that is converted into its active metabolite to inhibit viral RNA synthesis.
Synergy: Together, the combination prevents the Hepatitis C virus from multiplying and spreading, allowing the virus to be eliminated from the body.
Indications & Usage :
Used to treat chronic HCV infection in adults and children.
It can cure more than 95 %of Hepatitis C cases when taken for a standard duration of 8 to 24 weeks, depending on the viral genotype.
It is a prescription-only drug.
Pharmacokinetics :
Administration: Taken orally once daily, with or without food.
Metabolism: Sofosbuvir is extensively metabolized in the liver to form the active pharmacologic metabolite. Ledipasvir undergoes minor oxidative metabolism.
Excretion: Both components are primarily excreted via the feces (as unchanged drug) and urine.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
Keywords
